BusinessMRI Interventions, Inc. Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital SalesBy Nasdaq OMXMar 15, 2018, 1:00 PM UTC
BusinessMRI Interventions, Inc. to Announce Fourth Quarter and Full Year 2017 Results on March 15By Nasdaq OMXMar 8, 2018, 2:01 PM UTC
BusinessMRI Interventions, Inc. Announces Record 629 ClearPoint® Cases in 2017By Nasdaq OMXFeb 6, 2018, 1:09 PM UTC
BusinessMRI Interventions Recognizes FDA Clearance of Voyager’s Investigational New Drug Application for VY-AADC Allowing its Pivotal Program to Begin for Advanced Parkinson’s DiseaseBy Nasdaq OMXJan 24, 2018, 2:00 PM UTC
BusinessMRI Interventions ClearPoint® Neuro Navigation System Utilized for the First Time in MinnesotaBy Nasdaq OMXJan 3, 2018, 2:00 PM UTC
BusinessMRI Interventions to Present at LD Micro Main Event Conference on December 6By Nasdaq OMXNov 17, 2017, 2:00 PM UTC
BusinessMRI Interventions’ ClearPoint® NeuroNavigation System Achieves 2000th Procedure MilestoneBy Nasdaq OMXNov 16, 2017, 2:01 PM UTC
BusinessMRI Interventions ClearPoint® Neuro Navigation System to be Featured at SNO/SCIDOT Joint Conference on Therapeutic Delivery to the CNSBy Nasdaq OMXNov 13, 2017, 2:00 PM UTC
